NO20054465L - Topiske L-karnitinblandinger - Google Patents

Topiske L-karnitinblandinger

Info

Publication number
NO20054465L
NO20054465L NO20054465A NO20054465A NO20054465L NO 20054465 L NO20054465 L NO 20054465L NO 20054465 A NO20054465 A NO 20054465A NO 20054465 A NO20054465 A NO 20054465A NO 20054465 L NO20054465 L NO 20054465L
Authority
NO
Norway
Prior art keywords
carnitine
skin
topical
topical composition
approx
Prior art date
Application number
NO20054465A
Other languages
English (en)
Other versions
NO20054465D0 (no
Inventor
Jacob Guth
Michael Fred Czuczak
Vickie Lentner
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of NO20054465D0 publication Critical patent/NO20054465D0/no
Publication of NO20054465L publication Critical patent/NO20054465L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives en topisk blanding som omfatter (a) L-karnitin, et acyl-L-karnitin, et salt derav eller en blanding derav, og (b) én eller flere hydroksysyrer, proteolytiske enzymer, hudblekemidler eller en blanding derav, i en farmakologisk akseptabel bærer for topisk påføring. Den topiske blanding kan administreres for å bedre eller forhindre skadelige hudtilstander (f.eks. epidermal eksfoliasjon og tap av hudelastisitet), eksfoliere hud, aksellerere hudutskiftning og/eller bleke hud. For eksempel det kan administreres for å minske arrdannelse som følge av varicellainfeksjon, uttørking og avskalling som følge av solbrenthet, og for å bedre hudelastisitet. Den topiske blanding har fortrinnsvis en pH i området fra ca. 3,5 til ca. 8. Ifølge én utførelsesform, ligger pH i den topiske blanding innen området fra ca. 3,5 til ca. 6,5 eller 7. Ifølge en annen utførelsesform, ligger pH i den topiske blanding innen området fra ca. 6 til ca. 8 og fortrinnsvis fra ca. 6,5 til 7,5. Ifølge en foretrukket utførelsesform, er den topiske blanding fortrinnsvis tilnærmet fri for D-karnitin, acyl-D-karnitin og salter derav og, mer foretrukket, ytteligere tilnærmet fri for LD-karnitin, acyl-LD-karnitin og salter derav.
NO20054465A 2003-03-28 2005-09-27 Topiske L-karnitinblandinger NO20054465L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45882203P 2003-03-28 2003-03-28
PCT/US2004/009591 WO2004087072A2 (en) 2003-03-28 2004-03-29 Topical l-carnitine compositions

Publications (2)

Publication Number Publication Date
NO20054465D0 NO20054465D0 (no) 2005-09-27
NO20054465L true NO20054465L (no) 2005-12-12

Family

ID=33131830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054465A NO20054465L (no) 2003-03-28 2005-09-27 Topiske L-karnitinblandinger

Country Status (13)

Country Link
US (1) US20050100519A1 (no)
EP (1) EP1610760A4 (no)
JP (1) JP2006522807A (no)
KR (1) KR20050113669A (no)
CN (1) CN1964695A (no)
AU (1) AU2004226324A1 (no)
BR (1) BRPI0408834A (no)
CA (1) CA2519998A1 (no)
EA (1) EA200501413A1 (no)
MX (1) MXPA05010417A (no)
NO (1) NO20054465L (no)
WO (1) WO2004087072A2 (no)
ZA (1) ZA200507824B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416869B2 (en) * 2004-08-19 2008-08-26 Lonza Ltd. Enzyme delivery systems, application in water based products
ITMI20041603A1 (it) * 2004-08-04 2004-11-04 Vama Farmacosmetica S R L Materia prima cosmetica a base di 1-carnitina per preparato ad effetto idratante di lunga durata e preparato cosmetico ottenuto con questa materia prima
EP1649846A1 (de) * 2004-10-21 2006-04-26 Neubourg Skin Care GmbH & Co. KG Verwendung von Harnstoff zur Behandlung von Altersflecken
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
BRPI0712600B1 (pt) 2006-05-19 2015-10-27 Mary Kay Inc composição tópica para cuidados com a pele e método para a esfoliação da pele.
TW200831125A (en) * 2006-12-08 2008-08-01 Pola Chem Ind Inc A discrimination method of skin barrier function, the screening method of skin barrier function reinforced material by using the discrimination method, the skin barrier function reinforced materials, and the cosmetic material containing the skin barrier
MX2009012042A (es) * 2007-05-11 2009-12-01 Sigma Tau Ind Farmaceuti Gel util para el suministro de ingredientes activos cosmeticos.
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
KR101017586B1 (ko) * 2008-11-28 2011-02-28 (주)아모레퍼시픽 피부 미백용 화장료 조성물
FR2949969B1 (fr) * 2009-09-11 2012-08-03 Svr Lab Composition cosmetique a base d'uree pure, utilisation et procede d'application correspondant
DE102012214038A1 (de) * 2012-08-08 2014-02-13 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Harnstoff und Car-ni-tin und/oder einem oder mehreren Acyl-Carnitinen zur Behandlung und Prophylaxe von Neurodermitis sowie des diabetischen Fußes
EP2967045B1 (en) 2013-03-12 2019-06-26 Mary Kay, Inc. Preservative system
CN106102838A (zh) * 2014-06-02 2016-11-09 雅芳产品公司 局部用增亮组合物及其使用方法
US10182999B2 (en) 2014-08-18 2019-01-22 Francisco PAN-MONTOJO Glycolic acid enhances sperm mobility
ES2910653T3 (es) * 2015-01-27 2022-05-13 Professional Dietetics S P A In Forma Abbreviata P D S P A Composiciones que comprenden a) quitosano, b) ácido glicólico, c) carnitina y/o n-acetilcisteína para el tratamiento de descamación dermoepidérmica
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
KR101934022B1 (ko) * 2017-12-04 2018-12-31 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장용 조성물
KR20210011964A (ko) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
KR102253135B1 (ko) * 2018-07-17 2021-05-17 주식회사 엘지생활건강 각질 박리 증진용 화장료 조성물
WO2020017760A1 (ko) * 2018-07-17 2020-01-23 주식회사 엘지생활건강 각질 박리 증진용 화장료 조성물
KR102771004B1 (ko) * 2018-10-17 2025-02-21 주식회사 엘지생활건강 피부 각질 박리 촉진용 화장료 조성물
CN109528628B (zh) * 2018-12-14 2022-02-08 北京中医药大学 一种包含左卡尼汀的药用组合物及其制备方法和用途
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CA3199921A1 (en) * 2020-11-25 2022-06-02 Steven M. Hernandez Scar treatment composition
CN116981438A (zh) * 2021-03-08 2023-10-31 株式会社Lg生活健康 包含肉碱水杨酸盐作为有效成分的化妆料组合物
KR102744422B1 (ko) * 2021-03-08 2024-12-19 주식회사 엘지생활건강 카르니틴살리실레이트(ca-sa)를 유효성분으로 포함하는 화장료 조성물
WO2025258571A1 (ja) * 2024-06-12 2025-12-18 大阪ガスケミカル株式会社 ターンオーバー促進剤およびその用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683939A (en) * 1970-05-28 1972-08-15 Wilson Pharm & Chem Corp Proteinaceous cosmetic material for hair conditioning
JPS51148042A (en) * 1975-06-14 1976-12-18 Kanebo Ltd Skin toiletry
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
JPH0615462B2 (ja) * 1989-01-12 1994-03-02 レイコ 小阪 毛髪用組成物
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
JPH07157409A (ja) * 1993-12-07 1995-06-20 Kobe Steel Ltd 美白性化粧料
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
JP3229517B2 (ja) * 1995-04-18 2001-11-19 カネボウ株式会社 美白化粧料
JPH09263514A (ja) * 1996-03-29 1997-10-07 Shiseido Co Ltd 皮膚外用剤
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
JPH1129457A (ja) * 1997-07-04 1999-02-02 Kanebo Ltd 皮膚化粧料
JPH11180851A (ja) * 1997-12-22 1999-07-06 Kanebo Ltd 皮膚化粧料
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
JP3229594B2 (ja) * 1998-12-16 2001-11-19 カネボウ株式会社 美白化粧料
JP3874966B2 (ja) * 1999-05-11 2007-01-31 株式会社カネボウ化粧品 シート状美白パック化粧料
US6416769B1 (en) * 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
WO2001082878A1 (en) * 2000-05-02 2001-11-08 Perricone Nicholas V Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters
DE10129504A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen
MXPA04004478A (es) * 2001-11-13 2004-08-11 Procter & Gamble Composiciones que contienen enzimas estabilizadas con ciertos osmoprotectores y metodos para utilizarls en el cuidado personal.

Also Published As

Publication number Publication date
WO2004087072A2 (en) 2004-10-14
AU2004226324A1 (en) 2004-10-14
MXPA05010417A (es) 2005-11-04
CN1964695A (zh) 2007-05-16
WO2004087072A3 (en) 2006-04-27
EA200501413A1 (ru) 2006-10-27
KR20050113669A (ko) 2005-12-02
EP1610760A4 (en) 2008-01-09
BRPI0408834A (pt) 2006-04-04
ZA200507824B (en) 2007-04-25
EP1610760A2 (en) 2006-01-04
US20050100519A1 (en) 2005-05-12
CA2519998A1 (en) 2004-10-14
JP2006522807A (ja) 2006-10-05
NO20054465D0 (no) 2005-09-27

Similar Documents

Publication Publication Date Title
NO20054465L (no) Topiske L-karnitinblandinger
ES2604335T3 (es) Oxidación y aminación de alcoholes primarios
MXPA05011784A (es) Producto de caseina hidrolizada que comprende tripeptidos isoleucina-prolina-prolina y/o valina-prolina-prolina.
WO2004112732A3 (en) Modified soy proteins in skin tightening compositions
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
CY1107668T1 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
GEP20094725B (en) Process for production of optically active amine derivatives
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
MXPA03000089A (es) Uso de inhibidores de cinasa de tirosina de proteina de egf-r para prevenir el fotoenvejecimiento de la piel humana.
BR0212542A (pt) Método para a preparação de gluconato de cálcio, e, mistura de sal de glucomato/sal de ácido orgânico
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
AU2002214102A1 (en) Use of the association of at least a carotenoid with provitamin a activity and at least a carotenoid without provitamin a activity for treating ageing symptoms
CA2411582A1 (en) Method for increasing the antioxidative potential of selenium-containing aqueous solutions
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
WO2003059323A3 (de) Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
NO20033705D0 (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
DE60235889D1 (de) Reduktion des haarwachstums
PL1722748T3 (pl) Kompozycje do pielęgnacji skóry zawierające kwasy salicylowe
ATE459336T1 (de) Formulierung zur dermalen anwendung
TR200202439T2 (tr) Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1)
SE0201938D0 (sv) New process
BR9904948A (pt) Processo para a produção fermentativa de l-aminoácidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application